跳至主要内容
临床试验/NCT05486546
NCT05486546招募中不适用

Comparison of Visual Acuity and Quality of Life Following Contoura With Phorcides Compared to WaveLight Wavefront Optimized LASIK

Daniel Terveen6 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2022年8月15日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
120
试验地点
6
主要终点
Post-Op UDVA

研究概览

简要总结

Comparing post-operative visual acuity and patient reported satisfaction between Contoura with Phorcides and WaveLight Wavefront Optimized.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
21 Years 至 38 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Patients at least age 21 years of age undergoing LASIK eye surgery
  • Willing and able to comprehend informed consent and complete 1 month post-op visit
  • Potential postoperative BCDVA of 20/20 or better in each eye based on Investigator's medical opinion
  • Candidates for Contoura with Phorcides (Myopic, astigmatism <3.0D)
  • Both eyes targeted for plano
  • Pre-operative total corneal Pachymetry 490um or above
  • Stable refractive error <0.50D change in preceding year
  • Good general and ocular health
  • Pre-operative exam completed within three months of surgery
  • SCL discontinued 3 days prior to pre-op exam and the procedure
  • Pachymetry above 490 with residual greater than 270um
  • Candidates who, as determined by the investigator, can safely undergo LASIK

排除标准

  • Patients under 21 years of age
  • Concomitant ocular condition which would limit the BCVA at the discretion of the surgeon
  • Patients with usual relative and absolute contraindications for LASIK surgery (Patients with severe dry eye, recurrent corneal erosion, uncontrolled Glaucoma, collagen vascular disorders, keratoconus or signs of keratoconus, uncontrolled Diabetes, Herpes)
  • Pachymetry below 490
  • Autoimmune or immunodeficiency diseases
  • Pregnant or nursing women
  • Patients with signs of inability to understand consent for study and procedure planned
  • Patients with history of previous ocular surgery
  • Patients with strabismus or amblyopia
  • Patients that have a BCDVA of 20/25 or worse in either eye

结局指标

主要结局

Post-Op UDVA

时间窗: 3 months post-op

Percent of participants with monocular UDVA of 20/16 or better

次要结局

  • Pre-op and post-op visual acuity(3 months post-op)
  • Corrected Distance Visual Acuity(3 months post-op)
  • Low Contrast Visual Acuity(3 months post-op)
  • Post-OP BCVA(3 months post-op)
  • Residual Refractive Error(3 months post-op)

研究者

发起方
Daniel Terveen
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Daniel Terveen

Principal Investigator

Vance Thompson Vision

研究点 (6)

Loading locations...

相似试验